CAM
LH icon

Cresset Asset Management’s Labcorp LH Stock Holding History

Cresset Asset Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Sell
1,413
-896
-39% -$236K ﹤0.01% 1264
2026
Q1 		$616K Buy
2,309
+111
+5% +$30.1K ﹤0.01% 968
2025
Q4 		$551K Sell
2,198
-189
-8% -$50.2K ﹤0.01% 1030
2025
Q3 		$685K Buy
2,387
+341
+17% +$91.4K ﹤0.01% 891
2025
Q2 		$537K Buy
2,046
+4
+0.2% +$974 ﹤0.01% 897
2025
Q1 		$475K Sell
2,042
-704
-26% -$171K ﹤0.01% 1091
2024
Q4 		$630K Sell
2,746
-5,711
-68% -$1.31M ﹤0.01% 984
2024
Q3 		$1.89M Sell
8,457
-678
-7% -$149K 0.01% 842
2024
Q2 		$1.86M Buy
9,135
+159
+2% +$32.3K 0.01% 750
2024
Q1 		$1.96M Buy
8,976
+1,473
+20% +$324K 0.01% 646
2023
Q4 		$1.71M Buy
7,503
+1,156
+18% +$243K 0.01% 657
2023
Q3 		$1.28M Sell
6,347
-1,465
-19% -$309K ﹤0.01% 729
2023
Q2 		$1.62M Buy
7,812
+4,755
+156% +$922K ﹤0.01% 717
2023
Q1 		$603K Buy
3,057
+268
+10% +$55.1K 0.01% 442
2022
Q4 		$240K Sell
2,789
-138
-5% -$27K ﹤0.01% 599
2022
Q3 		$515K Sell
2,927
-574
-16% -$118K 0.01% 503
2022
Q2 		$694K Buy
3,501
+939
+37% +$200K 0.01% 463
2022
Q1 		$580K Sell
2,562
-785
-23% -$185K 0.01% 560
2021
Q4 		$904K Sell
3,347
-801
-19% -$198K 0.01% 488
2021
Q3 		$1M Buy
4,148
+250
+6% +$63K 0.01% 391
2021
Q2 		$925K Buy
3,898
+562
+17% +$128K 0.01% 380
2021
Q1 		$731K Buy
3,336
+1,028
+45% +$206K 0.01% 372
2020
Q4 		$404K Sell
2,308
-170
-7% -$29.4K 0.01% 463
2020
Q3 		$401K Buy
2,478
+20
+0.8% +$3.17K 0.01% 425
2020
Q2 		$351K Buy
+2,458
New +$340K 0.01% 419
2019
Q2 		– Sell
-573
Closed -$75K – 1132
2019
Q1 		$75K Buy
573
+31
+6% +$3.82K ﹤0.01% 651
2018
Q4 		$59K Buy
+542
New +$72.6K ﹤0.01% 441

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cresset Asset Management's LH Position: Q2 2026 in Review

Cresset Asset Management reduced its Labcorp (LH) stake by 39% in Q2 2026, selling an estimated $236K and leaving 1,413 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Cresset Asset Management first reported a position in LH in Q4 2018 and has held it in 27 quarters since. The position peaked at $1.96M in Q1 2024. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cresset Asset Management held 1,413 shares of Labcorp worth $396K as of Q2 2026.
  • Cresset Asset Management sold 896 Labcorp shares in Q2 2026, an estimated $236K.
  • Labcorp made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1264 holding.
  • Cresset Asset Management first reported a position in Labcorp in Q4 2018 and has held it in 27 quarters since.
  • Cresset Asset Management's Labcorp position peaked at $1.96M in Q1 2024.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.